Evidence map›Paper›PMID 39057407›Full record

ArticleMarine drugs2024

Identification of Axinellamines A and B as Anti-Tubercular Agents.

Emily J Strong, Lendl Tan, Sasha Hayes, Hayden Whyte, Rohan A Davis, Nicholas P West

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Marine drugs, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Marine natural products.Natural product reports · 2026
    Review
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Emily J StrongSchool of Chemistry and Molecular Biosciences, and the Australian Infectious Diseases Research Centre, The University of Queensland, Brisbane, QLD 4072, Australia.
Lendl TanSchool of Chemistry and Molecular Biosciences, and the Australian Infectious Diseases Research Centre, The University of Queensland, Brisbane, QLD 4072, Australia.ORCID 0000-0002-9955-2440
Sasha HayesGriffith Institute for Drug Discovery, School of Environment and Science, Griffith University, Brisbane, QLD 4111, Australia.ORCID 0000-0002-9168-4502
Hayden WhyteSchool of Chemistry and Molecular Biosciences, and the Australian Infectious Diseases Research Centre, The University of Queensland, Brisbane, QLD 4072, Australia.
Rohan A DavisGriffith Institute for Drug Discovery, School of Environment and Science, Griffith University, Brisbane, QLD 4111, Australia.ORCID 0000-0003-4291-7573
Nicholas P WestSchool of Chemistry and Molecular Biosciences, and the Australian Infectious Diseases Research Centre, The University of Queensland, Brisbane, QLD 4072, Australia.ORCID 0000-0003-0955-9890

Funding

Australian Research Council LE0668477, LE140100119, and LE0237908National Health and Medical Research Council GNT1164198
6 · The paper itself

Abstract

Tuberculosis remains a significant global health pandemic. There is an urgent need for new anti-tubercular agents to combat the rising incidence of drug resistance and to offer effective and additive therapeutic options. High-throughput screening of a subset of the NatureBank marine fraction library (

Indexed as

Antitubercular AgentsMicrobial Sensitivity TestsMycobacterium tuberculosisPoriferaAlkaloidsAnimalsHumansPyrrolesTuberculosisAlkaloidsAntitubercular AgentsPyrrolesalkaloidaxinellaminebiodiscoveryhaploscleridamarine spongeMycobacteriumnatural productsNatureBanktuberculosis

Identifiers

PMID39057407
PMCPMC11277618

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.